Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earlier this month, Canopy Growth Corporation (NASDAQ:CGC) (TSX:WEED) revealed a $CA16.3 million ($13.08 million) net loss in the second quarter of fiscal 2022 and a CA$77 million wider loss in EBITDA, versus the same period of last year. Moreover, the company pushed out a positive Adjusted EBITDA target due to market share challenges in the Canadian recreational business and a slower-than-expected ramp-up of US distribution for BioSteel, while revealing a 3% year-over-year decline in net revenue to CA$131 million.

Canopy Growth Is A 'Show-Me-Story' As It Posts Mixed Progress In KPIs, Analyst Argues

OrganiGram Holdings Inc.

SNDL Inc.

These three Canadian pot companies sport key features that should allow them to reward patient shareholders.

3 Risky Pot Stocks With Jaw-Dropping Growth Potential

Cronos Group

Tilray Brands

Barclays analyst Guarav Jain on Thursday initiated coverage of three cannabis stocks but said their businesses are limited by the relatively small size of the legal market in Canada. Barclays launched overage of Tilray TLRY, -4.86% and Cronos CRON, -4.48% with an underweight rating and price targets of $10 and $5.50 respectively.

Barclays initiates coverage of Tilray, Cronos and Canopy Growth

HEXO Corp

Canadian Cannabis Stocks In November The post Are You Looking For Top Marijuana Stocks Right Now? 2 Pot Stocks To Watch appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are You Looking For Top Marijuana Stocks Right Now? 2 Pot Stocks To Watch

On Wednesday, Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) unveiled a new lineup of premium flower offerings across its 7ACRES, 7ACRES Craft Collective and DOJA brands, including a range of national and limited-edition craft strains. The Canadian cannabis giant noted that these strains have been meticulously cultivated to meet the growing demand of the Canadian flower market.

Canopy Growth's New Lineup Of Premium Cannabis To Meet Canada's Growing Demand

This pot company's Q2 earnings make you wonder whether it is time to give up hope on its rebound.

Should Investors Abandon Canopy Growth After Its Q2 Earnings?

Curaleaf Holdings, Inc.

It's looking like a "buy the rumor, sell the news" day in Cannabis-land.

Why Canopy and Sundial Dropped Today, but Curaleaf Popped

Carnival

Disney

Dollar Tree

GameStop

Cyclical stocks in focus as cyclical market sentiment rises on China's October retail sales beat.

Top Cyclical Stocks To Invest In Now? 5 Names To Know

Heritage Cannabis Holdings Corp. (CSE:CANN) (OTCQX:HERTF) announced Monday that it has inked a commercial agreement with Canopy Growth Corp. (NASDAQ:CGC) for the supply of bulk concentrates, including live resin. Based in Toronto, the company recently provided the first shipment of live resin to the Canadian cannabis giant.

Heritage Cannabis: Will Supply Canopy Growth With Bulk Live Resin, Inks Commercial Deal, Completes First Shipment

Heritage Cannabis Holdings Corp said it has signed a commercial agreement with Canopy Growth Corp for the supply of bulk concentrates, including live resin. The company recently provided the first shipment of live resin to Canopy, with future purchase orders and shipments to follow.

Heritage Cannabis signs commercial agreement with Canopy Growth for the supply of bulk concentrates, including live resin

Producers have gotten into the habit of making incredibly aggressive forecasts.

1 Thing Canadian Cannabis Producers Should Stop Doing Right Now

Canopy Growth Corp. (NASDAQ:CGC) shares are trading higher Friday, possibly after Ohio's new Senate bill states that medical marijuana could be given to any patient who can be “reasonably expected to benefit” from it. The stock looks to be breaking out of a technical pattern and pushing higher.

Canopy Growth Breaks Past Resistance And Looks To Be Changing Trends

Aurora Cannabis

Investors are wondering why are marijuana stocks up today and we've got the latest answer to that burning question for Friday! The post SNDL, TLRY, ACB, CGC: Why Are Marijuana Stocks Up Today?

SNDL, TLRY, ACB, CGC: Why Are Marijuana Stocks Up Today?

Investors have some reason to hope that Congress might pass a marijuana legalization bill sooner than previously expected.

Why Tilray, Aurora Cannabis, and Canopy Growth Stocks Just Popped

A Republican-backed bill to legalize marijuana juiced the pot-magnate's stock this week.

Here's Why Canopy Growth Stock Rocketed Higher This Week

Marijuana legalization just got more probable -- and taxation more likely.

Why Aurora Cannabis, Canopy Growth, Tilray, and Sundial Growers Stocks Flamed Out on Wednesday

BioSteel Sports Nutrition Inc. announced Wednesday its latest collegiate athlete deal with women's basketball freshman phenom Azzi Fudd. Under the partnership, BioSteel takes the collegiate name, image and likeness (NIL) deals to the next level of endorsement, as Fudd agreed to become both a brand ambassador and partner of BioSteel, marking the signing as one of the first partnerships at the college level.

Canopy Growth's BioSteel Taps Woman's Basketball Prodigy Azzi Fudd As New Ambassador

Cannabis stocks are soaring, but Canopy Growth still trades at multi-year lows. The company pushed back on profitability guidance but reiterated FY24 guidance for positive free cash flow.

Where Will Canopy Growth Stock Be In 5 Years?

The cannabis sector has seen an uptick in volume this week, which has helped many of the stocks to begin to rebound after almost a full year of steady decline. High volume indicates a high level of trader and investor interest, which means those who have left the sector may be finding cannabis stocks attractive again.

Aurora, Canopy, Cronos And Tilray: Analyzing Cannabis Stocks For Short Squeeze Potential

JP Morgan rescinding news on cannabis stock restriction? GOP's legalization bill treats marijuana like alcohol?

$ACB Expands European Presence; $MSOS Sees Massive Volume Spike — Cannabis Daily November 8, 2021

Canopy Growth Corporation's (NASDAQ:CGC) stock took a deep plunge on Friday after the company announced a $CA16.3 million ($13.08 million) net loss in the second quarter and a CA$77 million wider loss in EBITDA, versus the same period of last year. The Canadian cannabis giant pushed out a positive Adjusted EBITDA target due to market share challenges in the Canadian recreational business and a slower-than-expected ramp-up of U.S. distribution for BioSteel, while revealing a 3% year-over-year decline in net revenue to CA$131 million.

What's Around The Corner For Canopy Growth? Analyst's Thoughts Post Earnings

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

AXS Cannabis ETF

Cannabis stocks posted big gains Monday amid optimism about M&A and federal legalization in a rare burst of energy in the sector that's been trading mostly lower this year.

Cannabis Watch: Cannabis stocks rally on talk of M&A and latest moves toward possible reform of federal ban

Wall Street predicted marijuana sector mergers -- and we just got one.

Why Curaleaf, Canopy Growth, and Hexo Stocks Are Glowing Green Today

The shares of Canopy Growth Corp (NASDAQ:CGC) are up 6.1% at $12.51 at last check.

Pot Stock Pops Despite Downgrades, Price-Target Cuts

Today's earnings report for Canopy Growth Corp. has sent shares of CGC stock plummeting as investors avoid the cannabis sector altogether. The post CGC Stock Alert: What Is Going on With Canopy Growth Today?

News for Canopy Growth Stock (CGC)